Ashwagandha can be effective COVID-19 preventive drug, finds research by IIT Delhi and Japan's AIST
The drug's development may take some time, and in the current scenario, these natural resources -- Ashwagandha and Propolis -- can offer some preventive or even therapeutic value, according to D Sundar, head of the Delhi Indian Institute of Technology's Biotechnology department.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Ashwagandha | Biotechnology | COVID-19 | India Health | Japan Health | Pharmaceuticals | Propolis